Erythromelalgia accompanying rosuvastatin-associated myopathy

Nevio Cimolai; Tomas Cimolai

doi:10.3315/jdcr.2009.1026

Erythromelalgia accompanying rosuvastatin-associated myopathy

J Dermatol Case Rep. 2009 Apr 5;3(1):1-3. doi: 10.3315/jdcr.2009.1026.

Authors

Nevio Cimolai¹, Tomas Cimolai

Affiliation

¹ The University of British Columbia, Vancouver, British Columbia, Canada.

Abstract

Background: Secondary erythromelalgia can occur due to various underlying medical disorders or drug toxicity.

Main observations: A 75-year old male developed acute secondary erythromelalgia following the onset of rosuvastatin use and associated myopathy. The illness was reversible after discontinuation of the pharmacological agent.

Conclusion: Secondary erythromelalgia may occur after rosuvastatin use, but this and other dermatological toxicities are rare.

Keywords: drug toxicity; erythromelalgia; rosuvastatin; statins.

Publication types

Case Reports